Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 3 March 2009, doi:10.1136/bmj.b864
Cite this as: BMJ 2009;338:b864
Ganapati Mudur
1 New Delhi
| The first 150 words of the full text of this article appear below. |
The Ministry of Health in India has undermined the countrys century old legacy of public sector vaccine production, exacerbated vaccine shortages, and jeopardised the immunisation programme, say several healthcare organisations in a complaint to the Indian Supreme Court.
A petition filed last week wants the court to revoke an order by the health ministry last year that had suspended production of vaccines at three government vaccine manufacturing plants. The ministry had said that the plants did not meet standards of good manufacturing practice.
The Central Research Institute, in Kasauli, in the northern state of Himachal Pradesh, the Pasteur Institute of India, in Coonoor, Tamil Nadu, and the Vaccine Laboratory, in Chennai, were producing vaccines against diphtheria, measles, whooping cough, polio, rabies, tetanus, tuberculosis, and yellow fever.
Senior health ministry officials said that inspections at these plants over the past five years had revealed structural, process, and documentation deficiencies.
But the
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?